Back to Search Start Over

Avadel Pharmaceuticals price target raised to $18 from $14 at Piper Sandler

Source :
The Fly. May 4, 2020
Publication Year :
2020

Abstract

Piper Sandler analyst David Amsellem raised the firm's price target on Avadel Pharmaceuticals to $18 from $14 and reiterates an Overweight rating on the shares following the company's recently completed [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
The Fly
Publication Type :
Periodical
Accession number :
edsgcl.622674130